enGene Holdings, Inc. (ENGN)
10.36
-0.26
(-2.45%)
USD |
NASDAQ |
Feb 20, 16:00
10.38
+0.02
(+0.14%)
After-Hours: 20:00
enGene Holdings Total Liabilities (Quarterly) : 53.76M for Oct. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 161.76M |
| Achieve Life Sciences, Inc. | 18.42M |
| Oncolytics Biotech, Inc. | 10.74M |
| Edesa Biotech, Inc. | 0.7562M |
| Lexaria Bioscience Corp. | 1.527M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 221.47M |
| Shareholders Equity (Quarterly) | 167.71M |
| Debt to Equity Ratio | 0.1896 |
| Current Ratio | 6.298 |
| Net Debt Paydown Yield | -0.37% |